An improved revenue plus stable profit has put Analabs highly undervalued. With its business model, dividend policy and its NTA. Analabs should worth a target at least RM 2.500. Lack of institutional holding is the key problem hindering the run.
Analabs – highly undervalued
This site uses Akismet to reduce spam. Learn how your comment data is processed.
J&J Investment Co. 
Leave a comment